|
ZA200903082B
|
|
Eslicarbazepine acetate and methods of use
|
|
PT103940A
|
|
Preparation of polyhyroxylated styleben
|
|
GB0720866D0
|
|
Novel precursors
|
|
WO2008012108A2
|
|
Process for the preparation of polyhydroxylated stilbenes via claisen condensation
|
|
GB0709695D0
|
|
Process
|
|
GB0708818D0
|
|
Compounds
|
|
GB0701965D0
|
|
Process
|
|
GB0701968D0
|
|
Compounds
|
|
GB0701969D0
|
|
Compounds
|
|
GB0701966D0
|
|
Process
|
|
GB0700773D0
|
|
Drug therapies
|
|
GB0700635D0
|
|
Therapy
|
|
EP1884508A1
|
|
Process for the preparation of polyhydroxylated stilbenes via claisen condensation
|
|
GB0610804D0
|
|
New crystal forms
|
|
GB0607317D0
|
|
10-Acyloxy-5H-dibenzo[b,f]azepine-5-carboxamides & their asymmetric hydrogenation to the chiral 10,11-dihydro derivatives
|
|
EP1845097A1
|
|
Oxadiazole derivatives as COMT inhibitors
|
|
GB0603008D0
|
|
Method
|
|
GB0600709D0
|
|
Drug combinations
|
|
US2006252746A1
|
|
Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
|
|
GB0515690D0
|
|
Asymmetric catalytic reduction
|
